Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DX25F6STQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $28,572
Award facts
- Contract value 100% obligated
- $28,571.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Renflexis 100 mg vials, with a ceiling value of $28,571.66 and a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order utilizing Amerisource Bergen's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, with performance of this order occurring at the company's Pennsylvania corporate office location.
Renflexis is a biosimilar to Remicade (infliximab) used primarily to treat inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ulcerative colitis. This delivery order represents routine pharmaceutical procurement through the Defense Logistics Agency's established vendor network, demonstrating AmerisourceBergen's continued role as a major supplier of specialty pharmaceuticals and medical commodities to Department of Defense healthcare operations. The contract is scheduled for completion by August 5, 2025, reflecting the standard rapid fulfillment timelines typical of delivery orders against established indefinite delivery contracts.
Quick answers
Who was awarded contract SPE2DX25F6STQ?
SPE2DX25F6STQ was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 4, 2025.
How much is contract SPE2DX25F6STQ worth?
The government has obligated $28,572 on SPE2DX25F6STQ.
Is contract SPE2DX25F6STQ an order under another contract?
Yes. SPE2DX25F6STQ is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6STQ competed?
The extent of competition for SPE2DX25F6STQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award